Condition
Musculoskeletal Complications
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 6 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownTestosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor TreatmentNCT01573442 · 2013-09-10
COMPLETEDA Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)NCT01824836 · 2013-06-11
ACTIVE_NOT_RECRUITINGS1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone TherapyNCT01598298 · 2013-05-15
COMPLETEDFirst-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung CancerNCT01097317 · 2009-09-01
UNKNOWNVitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast CancerNCT00416715 · 2006-10-01
COMPLETEDComparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the BoneNCT00458796 · 2006-03-01
TERMINATEDCommon interventions
placeboOTHER2quality-of-life assessmentPROCEDURE2anastrozoleDRUG1assessment of therapy complicationsPROCEDURE1calcium carbonateDIETARY_SUPPLEMENT1calcium citrateDIETARY_SUPPLEMENT1calcium glucarateDIETARY_SUPPLEMENT1calcium gluconateDRUG1carboplatinDRUG1cholecalciferolDIETARY_SUPPLEMENT1duloxetine hydrochlorideDRUG1fatigue assessment and managementPROCEDURE1laboratory biomarker analysisOTHER1letrozoleDRUG1musculoskeletal complications management/preventionPROCEDURE1neuromuscular electrical stimulationOTHER1physiologic testingOTHER1testosteroneDRUG1vinorelbine tartrateDRUG1zoledronic acidDRUG1
Leading sponsors
Trial status mix
COMPLETED3
ACTIVE_NOT_RECRUITING1
TERMINATED1
UNKNOWN1
Phase mix
NA2
PHASE22
PHASE32
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.